For many years, heat shock or stress proteins have been regarded as intracellular molecules that have a range of housekeeping and cytoprotective functions, only being released into the extracellular environment in pathological situations such as necrotic cell death. However, evidence is now accumulating to indicate that, under certain circumstances, these proteins can be released from cells in the absence of cellular necrosis, and that extracellular heat shock proteins have a range of immunoregulatory activities. The capacity of heat shock proteins to induce pro-inflammatory responses, together with the phylogenetic similarity between prokaryotic and eukaryotic heat shock proteins, has led to the proposition that these proteins provide a link between infection and autoimmune disease. Indeed, both elevated levels of antibodies to heat shock proteins and an enhanced immune reactivity to heat shock proteins have been noted in a variety of pathogenic disease states. However, further evaluation of heat shock protein reactivity in autoimmune disease and after transplantation has shown that, rather than promoting disease, reactivity to self-heat shock proteins can downregulate the disease process. It might be that self-reactivity to heat shock proteins is a physiological response that regulates the development and progression of pro-inflammatory immunity to these ubiquitously expressed molecules. The evolving evidence that heat shock proteins are present in the extracellular environment, that reactivity to heat shock proteins does not necessarily reflect adverse, pro-inflammatory responses and that the promotion of reactivity to self-heat shock proteins can downregulate pathogenic processes all suggest a potential role for heat shock proteins as therapeutic agents, rather than as therapeutic targets.
Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?
2 e x p e rt re vie w s in m o le c u la r m e d ic in e
It was in 1962 that Ritossa and co-workers first discovered that subjecting Drosophila melanogaster larvae to temperature shock induced specific gene activation (Ref. 1); however, it was not until 1974 that the first products of these genes were identified and the term 'heat shock protein' was adopted (Ref. 2) . Subsequent work has demonstrated that heat shock proteins are present, and can be induced, in all species and that they are among the most phylogenetically conserved proteins. Heat shock proteins are categorised into several families that are named on the basis of their approximate molecular mass (e.g. the 70 kDa Hsp70; Table 1 ). Under physiological conditions, some of these proteins function as molecular chaperones or proteases that have a number of intracellular functions. Chaperones are involved in the assembly and folding of oligomeric proteins, whereas proteases such as the ubiquitin-dependent proteasome 
Hsp70
Hsp70 (inducible) Cytoplasm/nucleus All: bind to extended polypeptides; prevent Hsc70 (cognate) Cytoplasm/peroxisome aggregation of unfolded peptides; dissociate some Grp78/BiP ER oligomers; bind ATP and show ATPase activity mtHsp70/Grp75 Mitochondria Hsp70 is involved in regulation of HSF1 activity and the repression of heat shock protein gene transcription
Hsp90
Hsp90 (α and β) Cytoplasm All: bind to other proteins; regulate protein activity; Grp94/gp96/Hsp100 ER prevent aggregation of re-folded peptide; correct assembly and folding of newly synthesised protein Hsp90 appears to be involved in maintaining the HSF1 monomeric state in non-stressful conditions; represents 1-2% of total protein
Hsp110
Hsp110 (human) Nucleolus/cytoplasm Thermal tolerance Apg-1 (mouse) Cytoplasm Protein refolding Hsp105 Cytoplasm
Abbreviations: ER, endoplasmic reticulum; TCP-1, tailless complex polypeptide; Grp, glucose-regulated protein; Hsp, heat shock protein; BiP, immunoglobulin heavy chain binding protein; mtHsp70, mitochondrial Hsp70; HSF1, heat shock factor 1; Apg-1, protein kinase essential for autophagy.
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3 e x p e rt re vie w s in m o le c u la r m e d ic in e mediate the degradation of damaged proteins (Refs 3, 4). The term heat shock proteins is somewhat of a misnomer, as they are not induced solely by heat shock. Indeed, in addition to being constitutively expressed (making up 5-10% of the total protein content under normal growth conditions), these proteins can be markedly induced (up to 15% of the total cellular protein content) by a range of cellular insults including increased temperature, oxidative stress, nutritional deficiencies, ultraviolet irradiation, exposure to chemicals (e.g. ethanol), viral infection, and ischaemia-reperfusion injury (Refs 5, 6) . Stressors that cause protein unfolding, misfolding or aggregation trigger a stress response that leads to the induction of gene transcription for proteins with the capacity to stabilise and re-fold proteins, thereby reestablishing the balance between protein synthesis, assembly and degradation.
Regulation of heat shock protein gene transcription is mediated by the interaction of the heat shock factor (HSF) transcription factors (of which the principal one in vertebrates is HSF1) with heat shock elements (HSEs) in the heat shock protein gene promoter regions (Refs 7, 8) . In the unstressed state, HSF1 is present in the cytoplasm as a latent monomeric molecule that is unable to bind to DNA. Under stressful conditions, HSF1 is hyperphosphorylated in a ras-dependent manner by members of the mitogen-activated protein kinase (MAPK) subfamilies (e.g. ERK1, JNK/SAPK, p38 protein kinase; Refs 9, 10). HSF1 is converted to phosphorylated trimers with the capacity to bind DNA, and translocates from the cytoplasm to the nucleus (reviewed in Ref. 11; see Fig. 1 ). The signal that activates HSF1 is thought to be a flux of newly synthesised non-native proteins (Ref. 8) . The consequences of HSF binding to its target, and the events that result in the ensuing transcription of heat shock genes, have been reviewed previously (Ref. 12) .
The generation of heat shock proteins must be only transient, even if exposure to stress is over a prolonged period, as a continued presence of heat shock proteins would adversely influence protein homeostasis and a variety of intracellular functions. One mechanism by which the activity of HSF1 is regulated is via the binding of Hsp70 to its transactivation domain, thereby leading to repression of heat shock gene transcription (Ref. 13) . The interaction between Hsp70 and HSF1 has no effect on DNA binding or the stressinduced phosphorylation state of HSF1 (Ref. 13) . A second mechanism that regulates heat shock protein synthesis is the interaction between heat shock protein binding factor 1 (HSBP1) and the active trimeric form of HSF1 and Hsp70, thereby inhibiting the capacity of HSF1 to bind to DNA (Ref. 14) . HSBP1 is predominantly localised in the nucleus and levels of HSBP1 mRNA have been shown to be present at high levels in a variety of cell lines and animal tissues and to be unaffected by heat shock (Ref. 14) .
This article reviews the current literature on heat shock proteins and their influence on pathogenic processes such as autoimmunity, organ allograft rejection and vascular disease. It highlights the evolving evidence that rather than being exclusively intracellular, heat shock proteins are present in, and can be released into, the extracellular compartment under physiological conditions and elicit a range of functions. Given the functional versatility of heat shock proteins and their capacity to mediate both induction and regulation of immunity, further studies aimed at understanding the mechanisms underlying these functions might reveal strategies by which heat shock proteins can be used as therapeutic agents either for the generation of protective immunity or for the downregulation of deleterious inflammatory conditions. 
Heat shock proteins as molecular chaperones

Heat shock proteins and heat shock protein reactivity in transplantation
In addition to autoimmune disease, heat shock proteins and reactivity to heat shock proteins have been associated with allograft rejection. Heat shock proteins are induced during graft preservation, ischaemia-reperfusion and surgery (Refs 46, 47, 48), and by the inflammatory process of the rejection response, including the localised production of cytokines by infiltrating leukocytes (Ref. 49). In rats, Hsp70 gene and protein expression are increased in rejecting cardiac allografts, and graft-infiltrating lymphocytes proliferate in response to recombinant mycobacterial Hsp65 and Hsp71 (Refs 50, 51, 52, 53). Heat shock protein expression is also induced in the intestinal epithelium and lamina propria after rat small-bowel transplantation and appears, in part at least, to be resistant to immunosuppression with tacrolimus (Ref. These findings have led to the proposition that heat shock protein expression in allograft tissue induces heat shock protein reactivity, thereby promoting the development of acute and chronic graft rejection (Refs 57, 58, 59). However, heat shock proteins are cytoprotective molecules and their induction in the peri-and immediate post-transplantation periods is likely to be a protective response targeted towards the Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?
6 e x p e rt re vie w s in m o le c u la r m e d ic in e maintenance of cell and tissue integrity. This is supported by reports that heat shock proteins attenuate preservation and ischaemia-reperfusion injury (Refs 57, 60, 61, 62, 63), and that they protect endothelial cells from neutrophil-mediated necrosis (Ref. 64 ) and a variety of cell types from oxidative injury (Refs 65, 66, 67). In addition, lower levels of Hsp70 in pre-liver-transplant biopsies and organ perfusates are associated with early graft loss (Ref. 68 ).
The precise influence of heat shock proteins on allograft survival is currently unclear. A direct involvement of Hsp60 in the rejection process has been suggested by the observations that skin from transgenic mice overexpressing Hsp60 transplanted into allogeneic recipients is rejected more rapidly than skin transplanted from wild-type donors (Ref. 69) . By contrast, skin transplanted into Hsp60-transgenic mice, in which spontaneous autoimmunity to Hsp60 is reduced, is rejected more slowly than skin grafted into wild-type recipients (Ref. 69) . However, further studies are required to define more clearly a direct role for heat shock proteins in the induction and progression of allograft rejection.
Heat shock proteins and heat shock protein reactivity in vascular disease
It is now apparent that there is an inflammatory component to vascular disease that involves the accumulation of monocytes and activated T cells in atherosclerotic lesions and the localised presence of pro-inflammatory cytokines (Refs 70, 71) . Evidence also suggests that the immunological component of the development of atherosclerosis might, at least in part, involve the expression of, and reactivity to, heat shock proteins (Ref. A role for Hsp60 in the induction of the inflammatory response that characterises atherosclerosis has also been suggested. Lipidladen cells formed from the uptake of oxidised low-density lipoprotein (LDL), via a 'scavenger' receptor that does not recognise native LDL, are a principal component of the atherosclerotic plaque. Exposure of the monocytic cell lines U937 and HL60 to oxidised LDL induces marked expression of Hsp60 (Ref. 75 ). These findings suggest that the inflammatory response associated with atherosclerosis might in part be promoted by the activation of T cells reactive with the Hsp60 that is expressed on monocytes within the lesion or released locally. Localised expression of heat shock proteins might also be influenced by haemodynamic factors, as raised blood pressure has direct effects on the vasculature (Refs 76, 77) and vessels subjected to greater mechanical and shear stress express heat shock proteins and are more prone to the development of atherosclerosis (Refs 72, 77, 78, 79) .
Humoral responses to heat shock proteins have also been implicated in vascular disease. 
Heat shock proteins in normal aging
Increasing age is associated with a reduced capacity to maintain homeostasis in all physiological systems and it might be that this results, in part at least, from a parallel and progressive decline in the ability to produce heat shock proteins. If this is so, an attenuated heat shock protein response could contribute to the increased susceptibility to environmental 
Heat shock protein release
Heat shock proteins are typically regarded as intracellular molecules; however, it is now apparent that heat shock proteins can be released into the extracellular compartment. It was reported in the late 1980s that heat shock proteins could be released from cultured rat embryo cells (Ref. 100) . Heat treatment of the cells broadened the spectrum of proteins released, from a small set of proteins including Hsc70 to a larger set including Hsp70 and Hsp110. It was suggested that the release of heat shock proteins might have resulted from changes in pH and gas tension, disruption of the diffusion layer at the cell surface or mechanical stresses associated with in vitro manipulations (Ref. 100). The release of heat shock proteins did not appear to be mediated via the common secretory pathway, as it was not blocked by the inhibitors colchicine and monensin (Ref. 100) . Nor did it result from cell lysis, as exposure of cells to low concentrations of non-ionic detergents indicated that Hsp70 is not readily released from damaged cells. Instead, a selective mechanism has been suggested. Evidence cited in favour of this is the fact that Hsp70 synthesised in the presence of the lysine amino acid analogue aminoethyl cysteine was not released from cells, probably due to an altered structure or function preventing its correct interaction with the specific release mechanism (Ref. Although it is clear that heat shock proteins are present and can be released into the peripheral circulation in response to several conditions, the physiological role of these proteins has yet to be defined. Evidence that heat shock proteins can elicit a range of biological and pro-inflammatory effects has stimulated interest in finding cell-surface receptors for these molecules. The existence of specific receptors for heat shock proteins was initially confirmed in studies demonstrating that the presentation of heat shock protein-associated peptides by major histocompatibility complex (MHC) class I molecules required receptormediated endocytosis (Refs 118, 119, 120), and the identities of receptors for heat shock proteins are now becoming apparent. The heat shock protein Hsp60 is an intercellular signalling molecule Hsp70 has also been shown to bind with high affinity to human monocytes and the CD14 molecule is involved in Hsp70-induced activation (Ref. 124 ). There appears to be a CD14-dependent interaction leading to intracellular calcium fluxes and the induction of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and a CD14-independent, but calcium-dependent, response that leads to TNF-α production (Ref. 124; see Fig. 3 ).
The cell-surface receptor for gp96 on dendritic cells (DCs) is downregulated as they undergo maturation (Ref. 125 ). This receptor has now been identified as the CD91 molecule (which is also known as the α2-macroglobulin receptor or the LDL-related protein), to which it binds directly (Ref. 126 ). In addition to gp96, the CD91 molecule has since been shown to be a common receptor for Hsp70, Hsp90 and calreticulin, all of which can mediate the induction of peptide-specific immunity as summarised below (Ref. 127) .
It is now clear that heat shock proteins have an intercellular signalling role as well as a chaperone function, and Asea and colleagues have coined the term 'chaperokine' for these ubiquitously expressed and versatile families of molecules (Ref. 124 ).
The potential therapeutic value of heat shock proteins
Some of the earliest evidence that heat shock proteins might have a therapeutic potential arose from the observations that exogenous members of the Hsp70 family protect spinal sensory neurons from axotomy-induced death and cultured aortic cells from heat stress (Refs 128, 129) . Subsequent work demonstrated that exogenous Hsp70 could also protect rabbit arterial smooth muscle cells subjected to serum Hsp60 induces several pro-inflammatory cytokines, and the signalling pathways responsible are yet to be fully clarified. It induces the secretion of interleukin 6 (IL-6) from human monocytes via signalling through CD14 and p38 mitogen-activated protein kinase, and binds to the Toll-like receptor 4 complex (Tlr4), for which CD14 is a co-receptor, to induce the expression of TNF-α and nitric oxide. It also induces the expression of a range of cytokines, including IL-12 and IL-15, through as yet uncharacterized pathways. Hsp70 acts through a CD14-dependent pathway to stimulate IL-1β, IL-6 and TNF-α production, and also a CD14-independent pathway that leads to TNF-α production, suggesting that CD14 is also a co-receptor for an as yet uncharacterised Hsp70 receptor. Both Hsp70 pathways are calcium dependent (fig003gps).
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10 e x p e rt re vie w s in m o le c u la r m e d ic in e deprivation, by a mechanism that involved cell association but not internalisation (Ref. 130 ).
There are a number of indications in which heat shock proteins might be of therapeutic value. To date, the majority of studies have focused on either their capacity to regulate inflammatory responses in autoimmune disease or their ability to induce peptide-specific immune responses against tumours and pathogenic organisms.
Modulation of inflammatory disease
Despite the association of heat shock protein expression and heat shock protein reactivity with autoimmunity, several observations question the proposition that self-heat shock protein reactivity has a direct pro-inflammatory role in autoimmune disease. Although the literature on the subject is less comprehensive, the situation might also be the same in the case of transplantation.
The normal T-cell repertoire includes cells reactive against autologous heat shock proteins ( Refs 20, 131, 132) . Although heat shock proteins have been considered to be intracellular proteins and therefore normally shielded from self-reactive T cells, it is now known that they are released from a variety of normal cells in culture (Refs 100, 101, 102, 103) , expressed on the cell surface (Ref. 133 ) and present in the peripheral circulation of normal individuals (Refs 107, 108, 111). As discussed below, it appears that T-cell reactivity to self-heat shock proteins is a protective phenotype, and it is interesting to note that peripheral blood T-cell responsiveness to self-and non-self-heat shock proteins segregates with their expression of CD45 isotypes. Human Hsp60 activates What is currently not known is the cytokinesecreting profiles of cells responding to the different heat shock proteins or specific peptides derived from them. This is of particular importance given the evidence from autoimmune disease that self-heat shock protein reactivity appears to induce a regulatory phenotype, whereas reactivity to non-self induces a proinflammatory phenotype, as is discussed below.
Autoimmune disease
In contrast to their proposed capacity to promote pathogenic processes such as autoimmune disease, T-cell reactivity to heat shock proteins can also protect against disease, as demonstrated by the capacity of Hsp60 and Hsp70 to downregulate autoimmune disease (Refs 30, 134, 135, 136, 137,  138, 139, 140, 141 ).
An insight into the possible mechanisms by which self-heat shock proteins might modulate autoimmune disease has come from the work of de Graeff-Meeder and co-workers (Ref. 134 ). In patients with juvenile chronic arthritis, in whom the disease follows a relapsing-remitting rather than progressive course, the presence of circulating T cells responsive to human (self) Hsp60 was beneficial. These T cells were of the regulatory T helper 2 (Th2) phenotype, whereas T cells reactive with the 65 kDa mycobacterial antigen Hsp65 displayed the inflammatory Th1 phenotype and their presence correlated with disease severity (Ref. Members of the Hsp70 family can also elicit protection from autoimmune disease, and Hsp71 from Mycobacterium tuberculosis can modulate experimental rat arthritis (Ref. 139) . In a similar way to Hsp60, the capacity of peptides from mycobacterial Hsp70 to protect against the subsequent induction of adjuvant arthritis in Lewis rats appears to be mediated via the production of suppressive cytokines, including IL-10 (Refs 144, 145).
Allograft immunity
The capacity of heat shock proteins to modify allograft rejection responses is less well defined; however, immunising recipient animals with self-Hsp60, or Hsp60 peptides that have the capacity to shift Hsp60 reactivity from a Th1 to 
Induction of peptide-specific immunity
In addition to their capacity to downregulate pro-inflammatory conditions the potential value of heat shock proteins for inducing protective immunity has been explored by several groups, primarily in the areas of tumour immunity and infectious disease.
Tumour immunity
It has been known for some time that heat shock proteins bind peptide (Refs 4, 147) and that heat shock proteins purified from cells chaperone a large number of peptides derived from the cells from which they are isolated -the so-called 'antigenic repertoire' of that cell (Ref. However, the immunological effects of heat shock proteins purified from tumour cells have a dual nature. The induction of immunity to methylcholanthrene-induced fibrosarcoma by the administration of gp96 purified from the tumour displays a consistent dose restriction: two intradermal administrations of <1 µg gp96 is ineffective; two doses of 1 µg induce immunity and provide optimal protection against tumour growth; and two doses of 10 µg do not protect (Ref. 155 ). The lack of protection at high doses of tumour-derived gp96 is an active, antigenspecific downregulation of tumour-specific immunity that can be adoptively transferred by CD4 + T cells purified from animals treated with high doses of tumour-derived gp96 (Ref. 155) . These findings are exciting as they suggest that immunisation with heat shock proteins that are chaperoning clinically relevant peptides might be an effective strategy for downregulating several diseases including autoimmunity. In that regard, gp96 purified from liver and pancreas of C57/B6 mice has been shown to elicit protection from autoimmune damage in NOD mice that is long term and can be adoptively transferred (Ref. 156) .
The mechanisms by which heat shock proteins can mediate peptide-specific immunity are yet to be clearly defined. Antigen-presenting cells (APCs) such as DCs and monocytes play a key role, as they have been shown to internalise heat shock proteins spontaneously by receptormediated endocytosis via the CD91 receptor, and direct chaperoned proteins/peptides into the intracellular pathway for MHC class I-restricted presentation to CD8 + T cells, concomitant with the induction of DC maturation and cytokine secretion (Refs 118, 126, 127; see Fig. 4 ). It is interesting to note that α2-macroglobulin, the originally described ligand for CD91, is also able to channel exogenous antigens into the endogenous pathway of antigen presentation via the same receptor (Ref. 157) .
The mechanism by which high doses of heat shock protein can induce immunoregulation is also unclear. In addition to inducing DC maturation and the expression of antigenpresenting and co-stimulatory molecules (Refs 105, 125), gp96 promotes the accumulation of DCs into the draining lymph node (Ref. 158 ). It might be that larger quantities of gp96 lead to a Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?
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Induction of immunity to infectious agents
The capacity of heat shock proteins to chaperone antigenic repertoires and induce specific immunity to them has led to studies evaluating whether the administration of heat shock proteins from virally transformed cells, or cells infected by pathogenic organisms, would induce specific immunity (Ref. 159) . This has been shown to be the case, and specific immunity has been induced by the administration of heat shock proteins isolated from SV40-transformed and influenza-infected cells (Refs 160, 161) . Peptide-specific cytolytic T cells and protective anti-viral immunity can also be induced by immunising mice with a mixture of gp96 or Hsp70 reconstituted with specific cytotoxic T lymphocyte epitopes from SV40, influenza virus and lymphocytic choriomeningitis virus ( Refs 162, 163, 164) . An alternative approach is to covalently link appropriate antigens to heat shock proteins; indeed, the immunisation of mice with the human immunodeficiency virus 1 (HIV-1) p24 protein covalently linked to mycobacterial Hsp70 elicits antibody, cytokine and lymphocyte proliferative responses (Ref. 165 ). Covalent linking is not 
Summary
There are clearly many aspects of heat shock protein biology that remain puzzling. On the one hand, reactivity to heat shock proteins appears to be associated with several pathological disease states, yet, on the other hand, heat shock proteins are ubiquitously expressed and reactivity to self-derived molecules can confer protection against a number of pro-inflammatory conditions. Future work will need to translate the experimental data on the capacity of heat shock proteins to induce tumour protection and immunity to infectious agents into the clinical environment and more fully evaluate the mechanisms by which these effects are induced and regulated. The observations that heat shock proteins can be released and that they can directly or indirectly elicit potent immunoregulatory activities give a new perspective on the roles of heat shock proteins and anti-heat shock protein reactivity in autoimmunity, transplantation, vascular disease and other conditions. It is the qualitative nature of the response to heat shock proteins rather than its presence per se that is important, and future experimental and clinical studies attempting to associate heat shock proteins with disease pathogenesis need to be designed to address these issues. It is also important to define definitively the specificity of any responses, so that the outcome can be attributed to self-or nonself-reactivity. By doing this, the contribution of infective agents to pathogenic processes such as autoimmunity and vascular disease can be truly evaluated.
Heat shock proteins are extremely versatile and potent molecules, the importance of which to biological processes is highlighted by the high degree to which their structure and function are phylogenetically conserved. Our knowledge of the physiological role of heat shock proteins is currently limited; however, a better understanding of their function and thereby the acquisition of the capacity to harness their power might lead to their use as therapeutic agents and revolutionise clinical practice in a number of areas (Fig. 5 ). Table   Table 1 . Major mammalian heat shock proteins and their function (tab001gps). 
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The Cell Stress Society International (CSSI) is a US-based organisation that promotes 'the organization of conferences related to stress response research and the publication and dissemination of related journals and monographs'.
http://www.sp.uconn.edu/%7Ehightowe/cssi/ Cell Stress & Chaperones is a 'multi-disciplinary peer-reviewed journal that captures the eclectic spirit of the cellular stress response field in a single, concentrated source of current information. The Journal publishes basic and applied research on cellular stress responses of animals, microorganisms and plants'.
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